NephroCheck Test, manufactured by San Diego-based Astute Medical, provides a score indicating the patient’s likelihood of developing acute kidney injury within the following 12 hours. There are currently no FDA-approved or cleared tests on the market assessing the risk of developing AKI.
More articles on the FDA:
Recent device recall is largest single-day event ever on FDA record
FDA fast tracks Pfizer’s C. diff vaccine
FDA releases API for medical device data
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
